<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="alternative prospective ways to find new medicines. zoopharmacology zoopharmacognosy zootherapy" exact="cancer" post="multidrug resistance (MDR) collateral sensitivity oncotherapy 1. Introduction Cancer"/>
 <result pre="drugs) can reduce tumor size and increase life expectancy [2,3]," exact="cancer" post="is still considered one of the main causes of"/>
 <result pre="developed countries [3,5]. Recent evidence points toward stem-like phenotypes in" exact="cancer" post="cells, promoted by cancer stem cells (CSCs), as the"/>
 <result pre="evidence points toward stem-like phenotypes in cancer cells, promoted by" exact="cancer" post="stem cells (CSCs), as the main culprit of cancer"/>
 <result pre="by cancer stem cells (CSCs), as the main culprit of" exact="cancer" post="relapse, resistance to radiotherapy, hormone therapy, and/or chemotherapy, and"/>
 <result pre="seems to be the main perpetrator of treatment failure in" exact="cancer" post="patients, usually after a relapse. Increasing evidence demonstrates that"/>
 <result pre="only the resistance mechanisms already present in the bulk of" exact="cancer" post="cells but also those activated in CSCs [3]. The"/>
 <result pre="radiation [3]. It may be possible that some nuclear medicine" exact="cancer" post="diagnostic and therapeutic techniques favoring autophagy resulting in the"/>
 <result pre="can lower intracellular drug concentration by expelling the drug from" exact="cancer" post="cells [5]. However, despite their great in vitro success,"/>
 <result pre="Zoopharmacognosy and Zootherapy) as an encouraging way to find new" exact="cancer" post="treatments in the context of helping to overcome MDR"/>
 <result pre="inhibiting drug transporters and/or by new drugs that hypersensitize resistant" exact="cancer" post="cells through collateral sensitivity (Figure 2). Different concepts related"/>
 <result pre="only on Level (4) since no clear examples to prevent" exact="cancer" post="are known. Level (4) comprises therapeutic behaviors in which"/>
 <result pre="in this case, to tumoral cells. The detrimental effect on" exact="cancer" post="cells must lead to increased host fitness. The substance"/>
 <result pre="common problem that sharing both infectious pathologies as well as" exact="cancer" post="disease. Albeit, the most classical example of self-medication behavior"/>
 <result pre="apoptotic) of this extract to the treatment of prostate [24]," exact="neuroblastoma" post="[25], and breast cancer, showing in the latter case"/>
 <result pre="extract to the treatment of prostate [24], neuroblastoma [25], and" exact="breast cancer," post="showing in the latter case a synergistic effect in"/>
 <result pre="extract showed activity in MDR breast, colorectal carcinoma, glioblastoma, and" exact="hepatocellular carcinoma" post="(in MDA-MB-231-BCRP, HCT116 (p53-/-), U87MG.âˆ†EGFR, HepG2 cancer cell lines"/>
 <result pre="glioblastoma, and hepatocellular carcinoma (in MDA-MB-231-BCRP, HCT116 (p53-/-), U87MG.âˆ†EGFR, HepG2" exact="cancer" post="cell lines respectively) [40]. Furthermore, it has been noticed"/>
 <result pre="been focused on the ethnopharmacological study of plants employed for" exact="cancer" post="treatment in African countries, showing the use by humans"/>
 <result pre="as Rubicordins A-C showed cytotoxicity against SGC-7901, A549, and HeLa" exact="cancer" post="cell lines which could be due to the inhibition"/>
 <result pre="response, which is associated with the development and progression of" exact="cancer" post="and inflammation. It has been proven that, on the"/>
 <result pre="through NF-ÎºÎ²/MAPK/Nrf2/HO1-signalling pathway. HO-1 is overexpressed in various types of" exact="cancer" post="and is further induced by radiation and chemotherapy. Regarding"/>
 <result pre="factor 2 (Nrf2) [54]. Mollugin also provoked mitochondrial-derived apoptosis in" exact="leukemia" post="Jurkat T cells [52]. Other species of this genus"/>
 <result pre="with bioactive properties for the treatment of resistant pathogens and" exact="cancer" post="in humans and their livestock by plant-based medicines [15,20,43]."/>
 <result pre="GLSDGEWQ) exhibit the most cytotoxic effect on MCF-7 breast human" exact="cancer" post="cell line and decrease the viability of stomach adenocarcinoma"/>
 <result pre="(Coragyps atratus) appear to show anticancer activity against hematopoietic system" exact="cancer" post="cell lines [70]. Some reptiles products are also being"/>
 <result pre="and besides, enhance the sensitivity of drug uptake by human" exact="cholangiocarcinoma" post="MDR cell line (QBC939/5-FU). In addition, their white blood"/>
 <result pre="extract of garden snail (Helix aspersa) has antitumor activity against" exact="breast cancer" post="cell line H5578T inducing necrosis; besides, it is a"/>
 <result pre="of garden snail (Helix aspersa) has antitumor activity against breast" exact="cancer" post="cell line H5578T inducing necrosis; besides, it is a"/>
 <result pre="have been found to reduce the proliferation of a B-cell" exact="lymphoma" post="cell line. Besides, shrimp anti-lipopolysaccharide factor (SALF) from black"/>
 <result pre="natural products with a reversal effect on multidrug resistance in" exact="cancer" post="mediated by drug transporter proteins, such as the works"/>
 <result pre="tumor growth inhibition toward drug-sensitive CCFR-CEM and P-glycoprotein overexpressing CEM/ADR5000" exact="leukemia" post="cells. Moreover, Venenum Bufonis (VB), a product of the"/>
 <result pre="exhibit antitumor, antinociceptive and anti-inflammatory activities in different types of" exact="cancer" post="[83]. It appears that these effects are mainly due"/>
 <result pre="of Epithelial-to Mesenchymal Transition and suppressed migration and invasion of" exact="lung cancer" post="cells [84]. Likewise, some products from the frog Physalaemus"/>
 <result pre="Epithelial-to Mesenchymal Transition and suppressed migration and invasion of lung" exact="cancer" post="cells [84]. Likewise, some products from the frog Physalaemus"/>
 <result pre="drugs such as methotrexate or cisplatin increases the cytotoxicity toward" exact="cancer" post="cells when compared to the effect of the drug"/>
 <result pre="mammalian leukemia, lymphoma, colon carcinoma, small cell lung, and gastric" exact="cancer" post="cells [96]. In other animals such as mammals, the"/>
 <result pre="were analyzed and screened, and the component/target/pathways network of anti-liver" exact="cancer" post="effect was constructed. The pathway enrichment results indicated that"/>
 <result pre="may play an antihepatoma role by inhibiting the development of" exact="hepatitis" post="B or acting on the key targets of the"/>
 <result pre="lipidomics-proteomics study of the mechanism of action of ArBu on" exact="liver cancer" post="and hepatoma cells to clarify its mechanism by bioinformatic"/>
 <result pre="study of the mechanism of action of ArBu on liver" exact="cancer" post="and hepatoma cells to clarify its mechanism by bioinformatic"/>
 <result pre="homeostasis which might be closely related to the mechanism of" exact="hepatocellular carcinoma." post="The lipidomics research revealed that lipid concentrations were regulated"/>
 <result pre="amino acids in HepG2 cells and affect the progression of" exact="liver cancer" post="as a potential arginine deiminase agonist. In summary, these"/>
 <result pre="acids in HepG2 cells and affect the progression of liver" exact="cancer" post="as a potential arginine deiminase agonist. In summary, these"/>
 <result pre="such as saponins and naphthoquinones unveiling in these studies as" exact="cancer" post="lead agents. The on-going tendency in Zootherapy is focused"/>
 <result pre="perspectivesCurr. Pharm. Des.2018244312433310.2174/138161282566619011016252930636587 3.Garcia-MayeaY.MirC.MassonF.PaciucciR.LLeonartM.E.Insights into new mechanisms and models of" exact="cancer" post="stem cell multidrug resistanceSemin. Cancer Biol.20206016618010.1016/j.semcancer.2019.07.02231369817 4.StewartB.W.WildC.P.World Cancer Report"/>
 <result pre="ionizing radiationRadiother. Oncol.20119928729210.1016/j.radonc.2011.06.00221722986 8.EfferthT.SaeedM.E.M.KadiogluO.SeoE.J.ShirooieS.MbavengA.T.NabaviS.M.KueteV.Collateral sensitivity of natural products in drug-resistant" exact="cancer" post="cellsBiotechnol. Adv.20203810734210.1016/j.biotechadv.2019.01.00930708024 9.CraggG.M.NewmanD.J.Natural products as sources of anticancer agents:"/>
 <result pre="of different extraction for Bismillah leaf (Vernonia amygdalina) in human" exact="glioblastoma multiforme" post="cell line (U-87)Biomed Res.20172814721478 26.WongF.C.WooC.C.HsuA.TanB.K.The anti-cancer activities of Vernonia"/>
 <result pre="Res.20172814721478 26.WongF.C.WooC.C.HsuA.TanB.K.The anti-cancer activities of Vernonia amygdalina extract in human" exact="breast cancer" post="cell lines are mediated through caspase-dependent and p53-independent pathwaysPLoS"/>
 <result pre="26.WongF.C.WooC.C.HsuA.TanB.K.The anti-cancer activities of Vernonia amygdalina extract in human breast" exact="cancer" post="cell lines are mediated through caspase-dependent and p53-independent pathwaysPLoS"/>
 <result pre="al.Cytotoxicity of 91 Kenyan indigenous medicinal plants towards human CCRF-CEM" exact="leukemia" post="cellsJ. Ethnopharmacol.201617917719610.1016/j.jep.2015.12.02826721219 30.SinghG.PasssariA.K.LeoV.V.MishraV.K.SubbarayanS.SinghB.P.KumarB.KumarS.GuptaV.K.LalhlenmawiaH.et al.Evaluation of phenolic content variability along"/>
 <result pre="methanol extracts of 10 Cameroonian medicinal plants towards multi-factorial drug-resistant" exact="cancer" post="cell linesBMC Complement. Altern. Med.20161626710.1186/s12906-016-1253-327484842 41.PetroniL.M.HuffmanM.A.RodriguesE.Medicinal plants in the"/>
 <result pre="NyangenaD.Azeze TeboT.NteziyaremyeP.Nyambura KaranjaL.JepchirchirA.et al.Medicinal plants used in traditional management of" exact="cancer" post="in Uganda: A review of ethnobotanical surveys, phytochemistry, and"/>
 <result pre="Altern. Med.20202020352908110.1155/2020/3529081 45.Ochwangâ€™iD.O.KimweleC.N.OdumaJ.A.GathumbiP.K.MbariaJ.M.KiamaS.G.Medicinal plants used in treatment and management of" exact="cancer" post="in Kakamega County, KenyaJ. Ethnopharmacol.20141511040105510.1016/j.jep.2013.11.05124362078 46.FarombiE.O.OwoeyeO.Antioxidative and chemopreventive properties"/>
 <result pre="heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human" exact="oral cancer" post="cellsBioMed Res. Int.2013201321060410.1155/2013/21060423738323 55.WangJ.LiL.WangJ.SongL.TanN.WangZ.Natural naphthohydroquinone dimer rubioncolin C exerts"/>
 <result pre="oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral" exact="cancer" post="cellsBioMed Res. Int.2013201321060410.1155/2013/21060423738323 55.WangJ.LiL.WangJ.SongL.TanN.WangZ.Natural naphthohydroquinone dimer rubioncolin C exerts"/>
 <result pre="death and inhibiting the NF-kappaB and Akt/mTOR/P70S6K pathway in human" exact="cancer" post="cellsCells20198159310.3390/cells8121593 56.van AsseldonkT.KleijerG.LansC.Ethnoveterinary herb use in the Netherlands-between ethnobotany"/>
 <result pre="review on cancer, TB, and HIV/AIDSMicrob. Pathog.20181259610710.1016/j.micpath.2018.09.00330195644 67.JangA.JoC.KangK.LeeM.Antimicrobial and human" exact="cancer" post="cell cytotoxic effect of synthetic angiotensin-converting enzyme (ACE) inhibitory"/>
 <result pre="black vulture (Coragyps atratus) in complementary and alternative therapies for" exact="cancer" post="in Colombia: A qualitative studyJ. Ethnobiol. Ethnomed.201282010.1186/1746-4269-8-2022651097 71.JeyamoganS.KhanN.A.SiddiquiR.Animals living"/>
 <result pre="potential source of anti-tumor molecule(s)Cancer Chemother. Pharmacol.20178091992410.1007/s00280-017-3410-x28795217 72.SongW.ShenD.Y.KangJ.H.LiS.S.ZhanH.W.ShiY.XiongY.X.LiangG.ChenQ.X.Apoptosis of human" exact="cholangiocarcinoma" post="cells induced by ESC-3 from Crocodylus siamensis bileWorld J."/>
 <result pre="Gekko sulfated polysaccharide on the proliferation and differentiation of hepatic" exact="cancer" post="cell lineCell Biol. Int.20063065966410.1016/j.cellbi.2006.04.00516757189 74.DingX.L.ManY.N.HaoJ.ZhuC.H.LiuC.YangX.WuX.Z.The antitumor effect of gekko"/>
 <result pre="extract on TNFÎ±, NF-ÎºB and some tumor suppressor genes in" exact="breast cancer" post="cell line Hs578TPharmacol. Mag.20171328128510.4103/0973-1296.204618 77.Ruiz-TorresV.EncinarJ.A.Herranz-LopezM.Perez-SanchezA.GalianoV.Barrajon-CatalanE.MicolV.An updated review on marine"/>
 <result pre="on TNFÎ±, NF-ÎºB and some tumor suppressor genes in breast" exact="cancer" post="cell line Hs578TPharmacol. Mag.20171328128510.4103/0973-1296.204618 77.Ruiz-TorresV.EncinarJ.A.Herranz-LopezM.Perez-SanchezA.GalianoV.Barrajon-CatalanE.MicolV.An updated review on marine"/>
 <result pre="The use of virtual screening for the discovery of small-molecule" exact="cancer" post="drugsMolecules201722103710.3390/molecules22071037 78.NewmanD.J.From natural products to drugsPhys. Sci. Rev.201842018011110.1515/psr-2018-0111 79.AbrahamI.El"/>
 <result pre="79.AbrahamI.El SayedK.ChenZ.S.GuoH.Current status on marine products with reversal effect on" exact="cancer" post="multidrug resistanceMar. Drugs2012102312232110.3390/md1010231223170086 80.LopezD.Martinez-LuisS.Marine natural products with P-glycoprotein inhibitor"/>
 <result pre="80.LopezD.Martinez-LuisS.Marine natural products with P-glycoprotein inhibitor propertiesMar. Drugs20141252554610.3390/md1201052524451193 81.LiuC.C.YangH.ZhangL.L.ZhangQ.ChenB.WangY.Biotoxins for" exact="cancer" post="therapyAsian Pac. J. Cancer Prev.2014154753475810.7314/APJCP.2014.15.12.475324998537 82.AbdelfatahS.LuX.Schmeda-HirschmannG.EfferthT.Cytotoxicity and antimitotic activity"/>
 <result pre="venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of" exact="lung cancer" post="cells via targeting IKKÎ²/NFÎºÎ² signal cascadeJ. Ethnopharmacol.202025011249210.1016/j.jep.2019.11249231866511 85.CalderonL.A.SobrinhoJ.C.ZaqueoK.D.De MouraA.A.GrabnerA.N.MazziM.V.MarcussiS.NomizoA.FernandesC.F.C.ZulianiJ.P.et"/>
 <result pre="inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung" exact="cancer" post="cells via targeting IKKÎ²/NFÎºÎ² signal cascadeJ. Ethnopharmacol.202025011249210.1016/j.jep.2019.11249231866511 85.CalderonL.A.SobrinhoJ.C.ZaqueoK.D.De MouraA.A.GrabnerA.N.MazziM.V.MarcussiS.NomizoA.FernandesC.F.C.ZulianiJ.P.et"/>
 <result pre="MouraA.A.GrabnerA.N.MazziM.V.MarcussiS.NomizoA.FernandesC.F.C.ZulianiJ.P.et al.Antitumoral activity of snake venom proteins: New trends in" exact="cancer" post="therapyBioMed Res. Int.2014201420363910.1155/2014/20363924683541 86.UrraF.A.Araya-MaturanaR.Targeting metastasis with snake toxins: Molecular"/>
 <result pre="Clin. Neurosci.201633525810.1016/j.jocn.2016.04.01227452128 88.DingJ.ChuaP.J.BayB.H.GopalakrishnakoneP.Scorpion venoms as a potential source of novel" exact="cancer" post="therapeutic compoundsExp. Biol. Med. (Maywood)201423938739310.1177/153537021351399124599885 89.VermaA.K.PrasadS.B.Antitumor effect of blister"/>
 <result pre="through the venoms from hymenoptera as potential therapeutic agents in" exact="cancer" post="therapyInt. J. Pharmacol.20171350751510.3923/ijp.2017.507.515 96.El-TantawyN.L.Helminthes and insects: Maladies or therapiesParasitol."/>
</results>
